Rising — Class II drug recall D-0724-2026
Ongoing recall by Rising Pharma Holding, Inc., reported 2026-07-29, distributed nationwide. Presence of Precipitate: medication was crystallizing and particles floating in the bottle
| Recall number | D-0724-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Rising Pharma Holding, Inc., East Brunswick, NJ, United States |
| Recall initiated | 2026-07-13 |
| Classified | 2026-07-23 |
| Reported by FDA | 2026-07-29 |
| Distributed | Nationwide (US) |
| Quantity | 74,208 units |
| NDC | 64980-0504, 64980-0504-48 |
| Lot numbers | CR2518, CR2601, CR2602, CR2603, CR2604, CR2605 |
| Expiration dates | 2027-11, 2027-12, 2028-01, 2028-02 |
Product
Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.
Reason for recall
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0724-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.